NanoViricides Inc. (NNVC)

[BonelessCat]

It was an estimated timeline based on information and assumptions available at the time. When the first rounds of animal studies were completed, the results were presented to the FDA and they were the ones who demanded far more testing of a novel drug and unproven drug. This was in spite of no evidence of counter indication or toxicity. That changed the timeline and is reflected in the dateless timeline that is currently on the website. It also changed the approach. Since the FDA was going to require dozens of pre-clinical tests, why not use those tests to expand the number of indications? That is how nnvc wound up with DengueCide as a front runner along with HSV.

None of this had anything to do with the length of time for mouse studies as you asserted. None of this has anything to do with missed deadlines. Even the timeline says that it is based on assumptions and that the company may not meet them. Finally, in the face of deadly viral outbreaks who 5 years ago would have thought the FDA would be so obstructive?

Have any more "deadlines" the company missed?